EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The differential interactomes of the KRAS splice variants identify BIRC6 as a ubiquitin ligase for KRAS4A

Juan Kochen Rossi, Cristina Nuevo-Tapioles, Rachel A O'Keefe, Moritz Hunkeler, Anna M Schmoker, Mercedes Fissore-O'Leary, Wenjuan Su, Ian M Ahearn, Cristina Branco, Hakyung Cheong, Dominic Esposito, Ioana Clotea und 3 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2024.115087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Juan Kochen Rossi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY 10016, USA. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Inhibitor of Apoptosis Proteins, Ubiquitin-Protein Ligases, Alternative Splicing. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins p21(ras)Inhibitor of Apoptosis ProteinsUbiquitin-Protein LigasesAlternative SplicingHumansUbiquitinationGolgi ApparatusProtein IsoformsApoptosisHEK293 CellsProtein Binding

Stichwörter der Autor:innen

BIRC6CP: Molecular biologyKRASKRAS4Aalternative splicinginhibitor of apoptosis proteinsoncogenepost-translational modificationubiquitination

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, humanInhibitor of Apoptosis ProteinsBIRC6 protein, humanUbiquitin-Protein LigasesProtein Isoforms

Autor:innen und Institutionen

  • Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY 10016, USA.
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY 10016, USA. Electronic address: mark.philips@nyulangone.org.

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • NYU Grossman School of Medicine
  • Ramon Areces Foundation
  • Astellas Pharma US
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Kochen Rossi, J., Nuevo-Tapioles, C., O'Keefe, R. A., Hunkeler, M., Schmoker, A. M., Fissore-O'Leary, M., Su, W., Ahearn, I. M., Branco, C., Cheong, H., Esposito, D., Clotea, I., Ueberheide, B., Fischer, E. S., & Philips, M. R. (2025). The differential interactomes of the KRAS splice variants identify BIRC6 as a ubiquitin ligase for KRAS4A. Cell Reports. https://doi.org/10.1016/j.celrep.2024.115087

Vancouver

Kochen Rossi J, Nuevo-Tapioles C, O'Keefe RA, Hunkeler M, Schmoker AM, Fissore-O'Leary M, et al. The differential interactomes of the KRAS splice variants identify BIRC6 as a ubiquitin ligase for KRAS4A. Cell Reports. 2025. doi:10.1016/j.celrep.2024.115087

BibTeX
@article{KochenRossi2025,
  author = {Kochen Rossi, Juan and Nuevo-Tapioles, Cristina and O'Keefe, Rachel A and Hunkeler, Moritz and Schmoker, Anna M and Fissore-O'Leary, Mercedes and Su, Wenjuan and Ahearn, Ian M and Branco, Cristina and Cheong, Hakyung and Esposito, Dominic and Clotea, Ioana and Ueberheide, Beatrix and Fischer, Eric S and Philips, Mark R},
  title = {The differential interactomes of the KRAS splice variants identify BIRC6 as a ubiquitin ligase for KRAS4A},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2024.115087}
}
Kostenlos starten →